Menu
GeneBe

19-7535576-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The ENST00000221249.10(PNPLA6):c.26T>C(p.Met9Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000344 in 1,452,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

PNPLA6
ENST00000221249.10 missense, splice_region

Scores

2
14
Splicing: ADA: 0.9196
1
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.656
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, PNPLA6
BP4
Computational evidence support a benign effect (MetaRNN=0.23395485).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PNPLA6NM_001166111.2 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 2/34
PNPLA6NM_001166113.1 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 3/35
PNPLA6NM_006702.5 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 3/35
PNPLA6NM_001166112.2 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 3/34

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PNPLA6ENST00000221249.10 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 3/351 A1Q8IY17-2
PNPLA6ENST00000450331.7 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 3/351 A1Q8IY17-2
PNPLA6ENST00000414982.7 linkuse as main transcriptc.26T>C p.Met9Thr missense_variant, splice_region_variant 2/342 Q8IY17-4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000344
AC:
5
AN:
1452596
Hom.:
0
Cov.:
31
AF XY:
0.00000416
AC XY:
3
AN XY:
721624
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000386
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000271
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 39 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeAug 23, 2023This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 9 of the PNPLA6 protein (p.Met9Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PNPLA6-related conditions. ClinVar contains an entry for this variant (Variation ID: 2202447). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.076
T
BayesDel_noAF
Benign
-0.35
Cadd
Benign
21
Dann
Uncertain
0.99
Eigen
Benign
-0.072
Eigen_PC
Benign
0.031
FATHMM_MKL
Benign
0.49
N
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.18
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationTaster
Benign
0.53
N;N;N;N
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.7
N;.;.;N;.;N;N;.;.
REVEL
Benign
0.092
Sift
Benign
0.048
D;.;.;D;.;D;D;.;.
Sift4G
Benign
0.57
T;T;T;T;T;D;T;T;T
Polyphen
0.087
B;.;.;.;.;.;B;.;.
Vest4
0.37
MutPred
0.23
Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);Gain of glycosylation at M9 (P = 0.0137);
MVP
0.42
MPC
1.4
ClinPred
0.97
D
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Varity_R
0.82
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.92
dbscSNV1_RF
Pathogenic
0.75
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-7600462; API